Furthermore, cancer-associated fibroblasts drive the selection of bone-metastatic breast cancer cells by selecting highly CXCL12- and IGF-1-responsive cells with an Src-dependent sensitivity for CXCL12- and IGF-1-mediated AKT activation [64]. This evidence concerns the gene CXCL12 and breast cancer.